Indication
Chronic granulomatous disease
Chronic granulomatous disease is a rare, inherited primary immunodeficiency disorder affecting innate immunity, most commonly diagnosed in childhood but occasionally identified in adults. Read more about Chronic granulomatous disease
3 drugs 3 manufacturers
Drugs that treat it
Common Chronic granulomatous disease therapies.
ACTIMMUNE (interferon gamma-1b,recomb.)
ACTIMMUNE (interferon gamma-1b,recomb.)
News & literature
Coming soonRelated codes
Coming soonRelated conditions & guidelines
Coming soonChronic granulomatous disease is a rare, inherited primary immunodeficiency disorder affecting innate immunity, most commonly diagnosed in childhood but occasionally identified in adults.
It is caused by genetic defects in the phagocyte nicotinamide adenine dinucleotide phosphate (NADPH) oxidase enzyme complex, which impairs the respiratory burst and prevents neutrophils, monocytes, and macrophages from producing the reactive oxygen species needed for microbial killing.
Pathophysiologically, this defect leads to recurrent, life-threatening bacterial and fungal infections—particularly by catalase-positive organisms—alongside excessive, dysregulated inflammation characterized by granuloma formation and tissue damage across organ systems such as the lungs, lymph nodes, liver, skin, and gastrointestinal tract.
- nih.gov
Chronic granulomatous disease is a rare, inherited primary immunodeficiency disorder affecting innate immunity, most commonly diagnosed in childhood but occasionally identified in adults
- nih.gov
Chronic granulomatous disease is a rare, inherited primary immunodeficiency disorder affecting innate immunity, most commonly diagnosed in childhood but occasionally identified in adults
- nih.gov
It is caused by genetic defects in the phagocyte nicotinamide adenine dinucleotide phosphate (NADPH) oxidase enzyme complex, which impairs the respiratory burst and prevents neutrophils, monocytes, and macrophages from producing the reactive oxygen species needed for microbial killing Pathophysiologically, this defect leads to recurrent, life-threatening bacterial and fungal infections—particularly by catalase-positive organisms—alongside excessive, dysregulated inflammation characterized by gra...
- nih.gov
It is caused by genetic defects in the phagocyte nicotinamide adenine dinucleotide phosphate (NADPH) oxidase enzyme complex, which impairs the respiratory burst and prevents neutrophils, monocytes, and macrophages from producing the reactive oxygen species needed for microbial killing
- nih.gov
It is caused by genetic defects in the phagocyte nicotinamide adenine dinucleotide phosphate (NADPH) oxidase enzyme complex, which impairs the respiratory burst and prevents neutrophils, monocytes, and macrophages from producing the reactive oxygen species needed for microbial killing
- nih.gov
Pathophysiologically, this defect leads to recurrent, life-threatening bacterial and fungal infections—particularly by catalase-positive organisms—alongside excessive, dysregulated inflammation characterized by granuloma formation and tissue damage across organ systems such as the lungs, lymph nodes, liver, skin, and gastrointestinal tract
Personalize your experience
Follow Chronic granulomatous disease and get updates as they land.
Already a member? Sign in
Follow an indication and get alerts when its drugs, labels, or guidelines change
Save any drug on this page to your favorites, synced across devices
AI-curated peer-reviewed research, summarized for your specialty
A morning digest of indication-relevant updates, when you want it
Sign in to follow this indication
Following an indication requires a free Physicians Office Resource account.